Key Metrics
63.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
>= 25
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.94
5-Year SI
5-year SI
- N/A 2-year SI
- 0.91 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
7.95
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Oncology
- Immunotherapy
- Assay
- Glioblastoma
- Clinical trial
- Breast cancer
- Colorectal cancer
- Antigen
- Cancer susceptibility
- Chimeric antigen receptor
- Antibody-drug conjugate
- Diffuse Glioma
- Immune checkpoint inhibitors
- Toxicity
- Adjuvant therapy
- Intraoperative radiotherapy
- Cancer immunotherapy
- Tumor microenvironment
- Cell therapy
- Lung cancer
Journal Specifications
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Website URL | Visit website |
Planning to publish in Nature Reviews Clinical Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
- 6 Nov 24
- Nature reviews. Clinical oncology
-
Full paper
On the cusp of targeted therapy for cancer cachexia-what clinical benefits might we promise our patients?
- 5 Nov 24
- Nature reviews. Clinical oncology
-
Full paper
Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia.
- 1 Nov 24
- Nature reviews. Clinical oncology
-
Full paper
Author Correction: The high costs of anticancer therapies in the USA: challenges, opportunities and progress.
- 30 Oct 24
- Nature reviews. Clinical oncology
-
Full paper
NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI3.
- 25 Oct 24
- Nature reviews. Clinical oncology
-
Full paper
Reply to 'NALIRIFOX in the frontline for metastatic pancreatic cancer: evidence beyond NAPOLI3'.
- 25 Oct 24
- Nature reviews. Clinical oncology
Scite analysis
Powered by scite_
3.1k articles received 166.2k citations see all
- 1,974 Supporting
- 162,010 Mentioning
- 195 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 33 Corrections
- 34 Errata
- 0 Expression of Concern
FAQs
How long has Nature Reviews Clinical Oncology been actively publishing?
Nature Reviews Clinical Oncology has been in operation since 2004 till date.
What is the publishing frequency of Nature Reviews Clinical Oncology ?
Nature Reviews Clinical Oncology published with a Monthly frequency.
How many articles did Nature Reviews Clinical Oncology publish last years ?
In 2023, Nature Reviews Clinical Oncology published 133 articles.
What is the eISSN & pISSN for Nature Reviews Clinical Oncology ?
For Nature Reviews Clinical Oncology,eISSN is 1759-4782 and pISSN is1759-4774.
What is Citescore for Nature Reviews Clinical Oncology ?
Citescore for Nature Reviews Clinical Oncology is 63.5.
What is SNIP score for Nature Reviews Clinical Oncology ?
SNIP score for Nature Reviews Clinical Oncology is 7.95.
Who is the publisher of Nature Reviews Clinical Oncology ?
NATURE PORTFOLIO is the publisher of Nature Reviews Clinical Oncology.